TY - JOUR
T1 - Age-specific associations between underlying health conditions and hospitalisation, death and in-hospital death among confirmed COVID-19 cases
T2 - a multi-country study based on surveillance data, June to December 2020
AU - Funk, Tjede
AU - Innocenti, Francesco
AU - Dias, Joana Gomes
AU - Nerlander, Lina
AU - Melillo, Tanya
AU - Gauci, Charmaine
AU - Melillo, Jackie M.
AU - Lenz, Patrik
AU - Sebestova, Helena
AU - Slezak, Pavel
AU - Vlckova, Iva
AU - Berild, Jacob Dag
AU - Mauroy, Camilla
AU - Seppälä, Elina
AU - Tønnessen, Ragnhild
AU - Vergison, Anne
AU - Mossong, Joël
AU - Masi, Silvana
AU - Huiart, Laetitia
AU - Cullen, Gillian
AU - Murphy, Niamh
AU - O’Connor, Lois
AU - O’Donnell, Joan
AU - Mook, Piers
AU - Pebody, Richard G.
AU - Bundle, Nick
N1 - Publisher Copyright:
© 2022 European Centre for Disease Prevention and Control (ECDC). All rights reserved.
PY - 2022/9/1
Y1 - 2022/9/1
N2 - Background: Underlying conditions are risk factors for severe COVID-19 outcomes but evidence is limited about how risks differ with age. Aim: We sought to estimate age-specific associations between underlying conditions and hospitalisation, death and in-hospital death among COVID-19 cases. Methods: We analysed case-based COVID-19 data submitted to The European Surveillance System between 2 June and 13 December 2020 by nine European countries. Eleven underlying conditions among cases with only one condition and the number of underlying conditions among multimorbid cases were used as exposures. Adjusted odds ratios (aOR) were estimated using 39 different age-adjusted and age-interaction multivariable logistic regression models, with marginal means from the latter used to estimate probabilities of severe outcome for each condition–age group combination. Results: Cancer, cardiac disorder, diabetes, immunodeficiency, kidney, liver and lung disease, neurological disorders and obesity were associated with elevated risk (aOR: 1.5–5.6) of hospitalisation and death, after controlling for age, sex, reporting period and country. As age increased, age-specific aOR were lower and predicted probabilities higher. However, for some conditions, predicted probabilities were at least as high in younger individuals with the condition as in older cases without it. In multimorbid patients, the aOR for severe disease increased with number of conditions for all outcomes and in all age groups. Conclusion: While supporting age-based vaccine roll-out, our findings could inform a more nuanced, age- and condition-specific approach to vaccine prioritisation. This is relevant as countries consider vaccination of younger people, boosters and dosing intervals in response to vaccine escape variants.
AB - Background: Underlying conditions are risk factors for severe COVID-19 outcomes but evidence is limited about how risks differ with age. Aim: We sought to estimate age-specific associations between underlying conditions and hospitalisation, death and in-hospital death among COVID-19 cases. Methods: We analysed case-based COVID-19 data submitted to The European Surveillance System between 2 June and 13 December 2020 by nine European countries. Eleven underlying conditions among cases with only one condition and the number of underlying conditions among multimorbid cases were used as exposures. Adjusted odds ratios (aOR) were estimated using 39 different age-adjusted and age-interaction multivariable logistic regression models, with marginal means from the latter used to estimate probabilities of severe outcome for each condition–age group combination. Results: Cancer, cardiac disorder, diabetes, immunodeficiency, kidney, liver and lung disease, neurological disorders and obesity were associated with elevated risk (aOR: 1.5–5.6) of hospitalisation and death, after controlling for age, sex, reporting period and country. As age increased, age-specific aOR were lower and predicted probabilities higher. However, for some conditions, predicted probabilities were at least as high in younger individuals with the condition as in older cases without it. In multimorbid patients, the aOR for severe disease increased with number of conditions for all outcomes and in all age groups. Conclusion: While supporting age-based vaccine roll-out, our findings could inform a more nuanced, age- and condition-specific approach to vaccine prioritisation. This is relevant as countries consider vaccination of younger people, boosters and dosing intervals in response to vaccine escape variants.
UR - http://www.scopus.com/inward/record.url?scp=85137104249&partnerID=8YFLogxK
U2 - 10.2807/1560-7917.ES.2022.27.35.2100883
DO - 10.2807/1560-7917.ES.2022.27.35.2100883
M3 - Article
C2 - 36052721
AN - SCOPUS:85137104249
SN - 1025-496X
VL - 27
JO - Eurosurveillance
JF - Eurosurveillance
IS - 35
ER -